bibliographic entry 12498296 [be/12498296]
https://w3id.org/oc/corpus/be/12498296

is a
content
  • Albertini, MR, Hank, JA, Gadbaw, B, Kostlevy, J, Haldeman, J, Schalch, H. Phase II trial of hu14.18-IL2 for patients with metastatic melanoma. Cancer Immunol Immunother (2012) 61: 2261–71. DOI: 10.1007/s00262-012-1286-5 PMID: 22678096
references